Strensiq 28 (Asfotase Alfa Vials) 40mg/ml-28mg/0.7ml

Strensiq 28 (asfotase alfa) is an enzyme replacement therapy delivered via 40mg/ml-28mg/0.7ml vials. Store between 2–8°C and protect from light. Suitable for patients requiring enzyme replacement therapy for specific metabolic conditions. Always follow healthcare provider instructions when using this medication.

Strength

40mg/ml-28mg/0.7ml

Pack Size

12s

Storage

2-8°

Manufacturer / TM Owner

Alexion

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Strensiq 28 (asfotase alfa) is used to treat patients with perinatal, infantile, or juvenile-onset hypophosphatasia, a rare metabolic bone disease. It replaces deficient tissue-nonspecific alkaline phosphatase to support bone mineralization. People often ask what is asfotase alfa used for when considering enzyme replacement options. This therapy helps manage symptoms related to impaired bone development and mineralization.

Side Effects

Asfotase alfa may help improve bone strength and mobility in eligible patients over time. Some users report reduced bone pain and fewer fractures after consistent use. Individual responses vary, and effects depend on adherence to prescribed treatment plans. Regular monitoring by a healthcare professional is recommended to assess progress.

Precautions & Warnings

Keep Strensiq 28 vials refrigerated between 2–8°C and use within the specified timeframe after preparation. Avoid shaking the vial; gently swirl if needed. Always check the solution for particles or discoloration before use. Dispose of used vials and supplies properly according to local guidelines. Consult your healthcare provider for personalized storage and handling advice.

Avoid Interactions

Limited data exist on interactions with asfotase alfa; however, caution is advised when combining with other injectable therapies. No specific drug-drug interactions have been widely reported. Always inform your healthcare provider about all medications and supplements you are taking before starting this therapy. Monitor for any unusual reactions when combining treatments.

References

Frequently Asked Questions

Asfotase alfa is used to treat hypophosphatasia, a rare genetic bone disorder affecting mineralization.

Store vials refrigerated between 2–8°C and protect from light; do not freeze.

Asfotase alfa is available by prescription; consult a healthcare provider for proper acquisition and use.

Common effects may include injection site reactions, headache, or nausea; report persistent issues to a doctor.

Safety during pregnancy has not been established; discuss risks and benefits with a healthcare professional.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.